ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab
NCT04272463
·
clinicaltrials.gov ↗
COMPLETED
Status
217
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Asthma
Interventions
OTHER:
No intervention
Sponsor
AstraZeneca